ACE2 and fatty liver disease: These data are in contrast to that by Biquard L. and colleagues, in which the authors showed that the expression of ACE2 and TMPRSS2 in the liver was not different in patients with metabolic-associated fatty liver disease even when the patients were stratified by BMI [35].